Leave a little sharper than you arrived.

Stool-based CRC screening slashes mortality — but only if patients actually do it

Participating in a fecal occult blood test (FOBT) screening program was linked to a 43% reduction in colorectal cancer (CRC) mortality, according to a large Swedish prospective study. Even just receiving an invitation to screen was tied to a 26% drop in CRC deaths. The catch? The benefit only materializes when patients follow through — making outreach and adherence critical.